CLEC2D anticorps

N° du produit ABIN7073248

Détail du produit anti-CLEC2D anticorps

Antigène: CLEC2D (C-Type Lectin Domain Family 2, Member D (CLEC2D))

Reactivité: Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CLEC2D est non-conjugé

Application: Western Blotting (WB)

Réactivité croisée: Rat

Purification: Affinity purification

Immunogène: Recombinant protein corresponding to Mouse CLEC2D

Information d'application

Indications d'application: WB (R) 1:500- 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.4, 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Détails sur CLEC2D

Antigène: CLEC2D (C-Type Lectin Domain Family 2, Member D (CLEC2D))

Autre désignation: CLEC2D (CLEC2D Produits)

Synonymes: anticorps CLAX, anticorps LLT1, anticorps OCIL, anticorps Clr-b, anticorps Clrb, anticorps Ocil, anticorps Clec2d5, anticorps CLEC2D, anticorps C-type lectin domain family 2 member D, anticorps C-type lectin domain family 2, member d, anticorps C-type lectin domain family 2, member D, anticorps CLEC2D, anticorps Clec2d

Sujet: CLEC2D (C-type lectin domain family 2 member D), also known as LLT1 (lectin-like transcript 1) or OCIL (Osteoclast inhibitory lectin), is a single-pass type II membrane protein expressed by hematopoietic cells and osteoblasts . Its expression was found to be tightly correlated with activation on T cells, NK cells, B cells, and DCs . CLEC2D is a ligand for the human NKR-P1A (CD161) receptor and that their interaction differentially regulates NK- and T-cell functions . It inhibits the formation and function of osteoclasts and modulates the release of interferon-gamma by human NK cells.

Poids moléculaire: 24 kDa

ID gène: 93694

NCBI Accession: NP_444339

UniProt: Q91V08

Pathways: Regulation of Leukocyte Mediated Immunity